These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21814754)

  • 1. Rheumatoid factor and antibodies against citrullinated peptides in Moroccan patients with rheumatoid arthritis: association with disease parameters and quality of life.
    Ibn Yacoub Y; Amine B; Laatiris A; Hajjaj-Hassouni N
    Clin Rheumatol; 2012 Feb; 31(2):329-34. PubMed ID: 21814754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in Moroccan patients with rheumatoid arthritis.
    Ibn Yacoub Y; Amine B; Laatiris A; Hajjaj-Hassouni N
    Clin Rheumatol; 2012 Oct; 31(10):1471-7. PubMed ID: 22903698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue and severity of rheumatoid arthritis in Moroccan patients.
    Ibn Yacoub Y; Amine B; Laatiris A; Wafki F; Znat F; Hajjaj-Hassouni N
    Rheumatol Int; 2012 Jul; 32(7):1901-7. PubMed ID: 21448644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.
    Hamad MB; Marzouk S; Kaddour N; Masmoudi H; Fakhfakh F; Rebai A; Bahloul Z; Maalej A
    J Clin Lab Anal; 2014 Jan; 28(1):21-6. PubMed ID: 24375820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood.
    Combier A; Frantz C; Wipff J; Bazeli R; Elhai M; Feydy A; Quartier P; Touanga Ngoti G; Thomas M; Deslandre C; Avouac J; Allanore Y
    Joint Bone Spine; 2023 Mar; 90(2):105501. PubMed ID: 36574572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disability and quality-of-life are not influenced by the prevalence of autoantibodies in early rheumatoid arthritis patients--results of the Brasília Cohort.
    Mota LM; Santos Neto LL; Burlingame RW; Ménard HA; Pereira IA; Carvalho JF; Laurindo IM
    Rev Bras Reumatol; 2012 Dec; 52(6):824-9. PubMed ID: 23223694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.
    Ursum J; Bos WH; van Dillen N; Dijkmans BA; van Schaardenburg D
    Arthritis Res Ther; 2010; 12(1):R8. PubMed ID: 20064278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
    Aletaha D; Alasti F; Smolen JS
    Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.
    Vittecoq O; Pouplin S; Krzanowska K; Jouen-Beades F; Menard JF; Gayet A; Daragon A; Tron F; Le Loet X
    Rheumatology (Oxford); 2003 Aug; 42(8):939-46. PubMed ID: 12730503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
    Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
    Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinsterhood and its impact on disease features in women with rheumatoid arthritis.
    Yacoub YI; Amine B; Laatiris A; Hajjaj-Hassouni N
    Health Qual Life Outcomes; 2011 Aug; 9():58. PubMed ID: 21806812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
    Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
    Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
    Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis.
    Nieto-Colonia AM; Santos WS; Keusseyan SP; Caldana W; Fernandes AR; Andrade LE
    Braz J Med Biol Res; 2008 Mar; 41(3):188-92. PubMed ID: 18235966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features.
    Ibn Yacoub Y; Amine B; Laatiris A; Wafki F; Znat F; Hajjaj-Hassouni N
    Clin Rheumatol; 2012 Mar; 31(3):479-82. PubMed ID: 22042491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.